These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8525152)

  • 1. Renal reserve in patients with high blood pressure.
    Gabbai FB
    Semin Nephrol; 1995 Sep; 15(5):482-7. PubMed ID: 8525152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is the kidney lesion caused by hypertension really ischemic?].
    Gabbai F; Herrera Acosta J
    Arch Inst Cardiol Mex; 1986; 56(1):81-7. PubMed ID: 2943250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy and mobilization of renal functional reserve.
    Burnier M; Biollaz J; Steinhauslin F; Brouard R; Waeber B; Brunner HR
    Clin Invest Med; 1991 Dec; 14(6):581-9. PubMed ID: 1686579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal functional reserve in experimental chronic glomerulonephritis.
    De Nicola L; Peterson OW; Obagi S; Kaiser JA; Wilson CB; Gabbai FB
    Nephrol Dial Transplant; 1994; 9(10):1383-9. PubMed ID: 7816249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of renal functional reserve of contralateral kidney of two-kidney, one clip Goldblatt hypertensive rats.
    Gabbai FB; Tapia E; Cermeño JL; Romero L; Bobadilla NA; Alvarado JA; Herrera-Acosta H
    J Hypertens Suppl; 1986 Dec; 4(5):S279-81. PubMed ID: 15362235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperfiltration as a factor in the progression of chronic kidney diseases].
    Kutyrina IM; Rogov VA; Shestakova MV; Zverev KV
    Ter Arkh; 1992; 64(6):10-5. PubMed ID: 1440323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibilities of achieving target blood pressure in patients with essential hypertension in relation to renal functional status and age].
    Dmitrova TB; Kotovskaia IuV; Kobalava ZhD; Moiseev VS
    Ter Arkh; 2002; 74(12):29-33. PubMed ID: 12577836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria.
    Eberhard OK; Kliem V; Offner G; Oldhafer K; Fangmann J; Pichlmay R; Koch KM; Brunkhorst R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):415-9. PubMed ID: 9361933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal reserve: a functional view of glomerular filtration rate.
    Bosch JP
    Semin Nephrol; 1995 Sep; 15(5):381-5. PubMed ID: 8525139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of acute functional injury following percutaneous renal artery intervention.
    Davies MG; Saad WE; Peden EK; Mohiuddin IT; Naoum JJ; Lumsden AB
    Ann Vasc Surg; 2008 Nov; 22(6):783-9. PubMed ID: 18692990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
    Siewert-Delle A
    Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern antihypertensive treatment and the progression of renal disease.
    Bauer JH
    J Hypertens Suppl; 1998 Oct; 16(5):S17-24. PubMed ID: 9869000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of blood pressure-lowering treatment of essential hypertension on kidney vasculature and kidney function].
    Birkenhäger WH
    Verh K Acad Geneeskd Belg; 1994; 56(3):165-85; discussion 185-90. PubMed ID: 8053262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal adaptive mechanisms in aged and hypertensive humans: possible effects of treatment.
    Di Serio C; Cristofari C; Torrini M; Cantini C; Lambertucci L; Castellani S; Masotti G; Ungar A
    Med Sci Monit; 2001; 7(6):1203-11. PubMed ID: 11687731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of intravenous amino acid administration in humans with and without renal disease: hormonal correlates.
    ter Wee PM
    Semin Nephrol; 1995 Sep; 15(5):426-32. PubMed ID: 8525145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.